Review
doi: 10.1007/978-3-642-74430-3_21.
Inhibition of desipramine 2-hydroxylation by quinidine and quinine in rapid and slow debrisoquine hydroxylators
Affiliations
- PMID: 2687858
- DOI: 10.1007/978-3-642-74430-3_21
Item in Clipboard
Review
Inhibition of desipramine 2-hydroxylation by quinidine and quinine in rapid and slow debrisoquine hydroxylators
Psychopharmacol Ser.
1989.
No abstract available
Similar articles
-
Inhibition of desipramine 2-hydroxylation by quinidine and quinine.Clin Pharmacol Ther. 1988 May;43(5):577-81. doi: 10.1038/clpt.1988.76. Clin Pharmacol Ther. 1988. PMID: 3365919
-
Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment.Pharmacol Toxicol. 1987 Apr;60(4):312-4. doi: 10.1111/j.1600-0773.1987.tb01758.x. Pharmacol Toxicol. 1987. PMID: 3588528
-
Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.Br J Clin Pharmacol. 1986 Dec;22(6):739-43. doi: 10.1111/j.1365-2125.1986.tb02969.x. Br J Clin Pharmacol. 1986. PMID: 3567021 Free PMC article.
-
Hydroxylation of desmethylimipramine: dependence on the debrisoquin hydroxylation phenotype.Clin Pharmacol Ther. 1987 Mar;41(3):314-9. doi: 10.1038/clpt.1987.33. Clin Pharmacol Ther. 1987. PMID: 3816019
-
Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation.Prog Clin Biol Res. 1986;214:169-88. Prog Clin Biol Res. 1986. PMID: 3523507 Review.
Cited by
-
Clinically significant drug interactions with antidepressants in the elderly.Drugs Aging. 2002;19(4):299-320. doi: 10.2165/00002512-200219040-00004. Drugs Aging. 2002. PMID: 12038880 Review.
-
Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man.Eur J Clin Pharmacol. 2003 May;59(1):23-8. doi: 10.1007/s00228-003-0575-5. Epub 2003 Mar 11. Eur J Clin Pharmacol. 2003. PMID: 12743670 Clinical Trial.